The c.1396C>T (NM_000536.4) variant in RAG2 is a missense variant predicted to cause the substitution of Leucine by Phenylalanine at amino acid 466 (p.Leu466Phe). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant is located in the PHD domain, amino acids 414-487 of RAG2, which is defined as a critical functional domain by the ClinGen SCID VCEP (PMID: 26996199); PM1_Moderate. One patient from Invitae presents carries this variant in trans with c.1352G>C (p.Gly451Ala) (classified as Likely Pathogenic according to SCID VCEP specifications). The parents were also tested; each was heterozygous for one variant - variants are in trans. 1 point, PM3 is met. The patient carrying this variant presents: T-B-NK+ lymphocyte subset profile 0.5 pts + SCID gene panel or exome/genome sequencing conducted 0.5 pts; + Diagnostic criteria for SCID/Leaky SCID/Omenn syndrome 0.5 pts; Total is 1.5 points, PP4 is met. In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive recombinase activating gene 2 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PM2_Supporting, PM1_Moderate, PP4, and PM3 (VCEP specifications version 1.0).